Accanis Biotech
VerifiedA developing optimized, proprietary in IVT mRNA with broad and long-acting therapeutic potential surpassing protein-based therapeutics.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
Related Content
Recent News about Accanis Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.